Arcus Biosciences News

Arcus Biosciences | ARS: Annual Report to Security Holders

Apr 24 06:03 ET

Arcus Biosciences | DEFA14A: Others

Apr 23 16:16 ET

Arcus Biosciences | DEF 14A: Definitive information statements

Apr 23 16:11 ET

Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer

Mar 29 16:24 ET

Arcus Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 27 16:16 ET

Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer

Mar 20 16:24 ET

Arcus Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 16:36 ET

Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer

Feb 28 19:59 ET

Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jaen Juan C.

Feb 28 19:59 ET

Arcus Biosciences | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Goeltz II Robert C.

Feb 23 17:55 ET

Arcus Biosciences | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 21 16:57 ET

Arcus Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 21 16:40 ET

Arcus Biosciences | 10-K: Annual report

Feb 21 16:21 ET

Arcus Biosciences | 8-K: Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update

Feb 21 16:14 ET

Arcus Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.25%)

Feb 13 22:58 ET

Arcus Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.317%),Abigail P. Johnson(6.317%)

Feb 9 08:40 ET

Arcus Biosciences | 3: Initial statement of beneficial ownership of securities-Director Mercier Johanna

Feb 7 19:02 ET

Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.

Jan 31 17:04 ET

Arcus Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Gilead Sciences, Inc.(35%)

Jan 31 17:03 ET

Arcus Biosciences | 8-K: Current report

Jan 30 08:22 ET